Full title (250 characters max):Recalcitrance of Cannabis sativa to de novo regeneration; a multi-genotype replication study Short title (100 characters max):Recalcitrance of Cannabis sativa to de novo regeneration methods Abstract 2Cannabis sativa is relatively recalcitrant to regeneration from somatic tissues, but several 3 reports have been published demonstrating a response. Most reports show low levels of 4 regeneration from somatic tissues, but a landmark publication by Lata et al. in 2010 reported 5 regeneration from leaf explants with a 96% response rate, producing an average of 12.3 shoots 6 per explant in a single, high-THC genotype. Despite the importance regeneration plays in plant 7 biotechnology this protocol has not been used in subsequent papers in the decade since it was 8 published, raising the concern that it is not reproducible. Many researchers are looking to build 9 research programmes in this growing field, and it is important that the reproducibility and 10 robustness of single-genotype C. sativa regeneration protocols undergo multi-lab validations to 11 ensure they are reproducible across the species. Replication studies in this burgeoning field will 12 help research groups avoid lost time and resources which arise from pursuing protocols that are 13 not reproducible. Here we test the replicability of this protocol across 10 drug-type C. sativa 14 genotypes. This protocol successfully induced callus in all 10 genotypes. Callus size and 15 appearance substantially differed among cultivars, with the most responsive genotype producing 16 6-fold more callus than the least responsive genotype. However, the most successful shoot 17 induction medium developed in the 2010 paper failed to induce regeneration in any of the 18 cultivars tested, resulting in the eventual necrosis of the calli. Based on this replication study, it 19 is evident that the existing regeneration protocol is not robust and could not be replicated in any 20 of the 10 genotypes tested. 4 22 2 Introduction 23 Plant tissue culture provides the foundation for advanced biotechnological techniques 24 such as protoplast systems, microspore culture for double haploid production, transgenics, 25 genome editing, and other important tools which have yet to be explored in Cannabis sativa L. 26 Due to prohibition, early micropropagation studies of Cannabis were limited in number and 27 scope. As a result, the majority of past research relied on single drug-type genotypes or on less 28 regulated industrial hemp (Cannabis sativa with <0. 0.03% w/w THC in the flowering heads) [1] 29 cultivars as a proxy for drug type Cannabis. These early studies found that both drug-type 30 Cannabis (high THC and/or high CBD) and industrial hemp can be maintained in vitro [2-4] and 31 that in vitro grown C. sativa display comparable chemical and physical profiles to greenhouse-32 grown counterparts [2], with no significant effect on the cannabinoid contents of high-THC 33 genotypes [4,5]. Regulations surrounding the production and consumption of Cannabis h...